Drug Profile
LAM 003
Alternative Names: LAM-003Latest Information Update: 04 Oct 2023
Price :
$50
*
At a glance
- Originator Undisclosed
- Developer OrphAI Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action HSP90 heat-shock protein inhibitors; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute myeloid leukaemia